The Latest
Op-EdsBuild Back Better is bad for the states
The Hill: The BBBA will force states to fund unsustainable programs and blur the lines between the federal and state governments.
The WasteWatcherNew Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
Letters to OfficialsCCAGW Joins Coalition Requesting Investigation into FTC "Zombie" Votes
December 2, 2021 Andrew Katsaros Inspector General, Federal Trade Commisssion The Honorable Maria Cantwell Chair, Senate Committee on Commerce, Science and Transportation
The WasteWatcherBuild Back Better Act Nicotine Tax Fails to Improve Public Health and Funds Wasteful Spending
The Build Back Better Act contains a nicotine tax that negatively impacts tobacco harm reduction efforts and public health.
Tobacco Harm Reduction Products Should Be Widely Adopted
CAGW’s latest issue brief analyzes tobacco harm reduction strategies worldwide.
The WasteWatcherFederal Agencies Must Stop Interfering with 5G Deployment
Federal agencies must stop objecting to the FCC's decisions to open up spectrum for much-needed 5G deployment.
State ActionCCAGW Urges Michigan Legislature to Oppose HB 4348
HB 4348 would harm the ability of PBMs to use a variety of tools and policies that help clients manage their pharmacy benefits and lower drug costs.
The WasteWatcherHouse Votes for Biden’s Build Back Broke Bill
The BBBA is a disastrous and wasteful bill that will raise costs further for all Americans and increase government control.
The WasteWatcherMethane Taxes Will Stifle American Energy Production
Methane taxes will damage American energy production and put the country further into debt.
Letters to OfficialsCAGW Sends "Pharmaceutical Price Controls are Bad Medicine" to Congress
Drug price controls will threaten medical innovation, reduce research and development, and cost American jobs.
The WasteWatcherBuild Back Better Act Will Destroy Vibrant U.S. Pharmaceutical Industry
CAGW's latest report “Price Controls on Pharmaceuticals Are Bad Medicine,” analyzes destructive policies in the BBBA.
Pharmaceutical Price Controls are Bad Medicine
Price controls will result in increased drug prices, less innovation, and fewer new drugs.
